ID   UCD-Mel-N(Ski+)
AC   CVCL_WS22
SY   UCD(SKI+)
DR   Wikidata; Q98133830
RX   PubMed=10811875;
RX   PubMed=14583455;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10896; SKI.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS21 ! UCD-Mel-N
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 7
CH   CVCL_WS23 ! UCD-Mel-N(Ski+/Fhl2+)
//
RX   PubMed=14583455;
RA   Chen, Da-Hu
RA   Xu, Wei-Dong
RA   Bales, Elise S.
RA   Colmenares, Clemencia
RA   Conacci-Sorrell, Maralice
RA   Ishii, Shunsuke
RA   Stavnezer, Ed
RA   Campisi, Judith
RA   Fisher, David Erich
RA   Ben-Ze'ev, Avri
RA   Medrano, Estela E.
RT   "SKI activates Wnt/beta-catenin signaling in human melanoma.";
RL   Cancer Res. 63:6626-6634(2003).
//
RX   PubMed=10811875; DOI=10.1073/pnas.090097797; PMCID=PMC18535;
RA   Xu, Wei-Dong
RA   Angelis, Konstantina
RA   Danielpour, David
RA   Haddad, Maher M.
RA   Bischof, Oliver
RA   Campisi, Judith
RA   Stavnezer, Ed
RA   Medrano, Estela E.
RT   "Ski acts as a co-repressor with Smad2 and Smad3 to regulate the
RT   response to type beta transforming growth factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5924-5929(2000).
//